Fej-nyaki daganatok: vizsgálatok itt: Kína
217 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in KínaNeoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCC
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 9
- Run by
- West China Hospital
See details and how to joinNCT07572864 - No phaseTaking peopleTai Chi for Cancer-Related Fatigue During Radiotherapy in Patients With Head and Neck Cancer
- Where
- Chengdu
- Életkor
- 18 év to 80 év
- People
- 116
- Run by
- West China Hospital
See details and how to joinNCT07809776 - 2. fázisNot yet taking people in KínaNimotuzumab Plus Radiotherapy in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Beijing
- Életkor
- 65 év and over
- People
- 46
- Run by
- Ke Hu
See details and how to joinNCT07821242 - 2. fázisTaking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Anyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jining, Kunming, Nanchang, Nanjing, Nanning, Shandong, Shanghai, Shenyang, Tianjin, Wuhan, Wuhou District, Zhengzhou
- Életkor
- 18 év to 64 év
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - 2. fázisTaking peopleA Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Chengdu
- Életkor
- 18 év to 70 év
- People
- 90
- Run by
- West China Hospital
See details and how to joinNCT07381075 - 2. fázisNot yet taking people in KínaRimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell Carcinoma
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 220
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07812467 - 2. fázisTaking peopleBecotatug Vedotin Plus Pucotenlimab and Platinum Chemotherapy in Locally Advanced Epidermal Growth Factor Receptor (EGFR)-Positive Head and Neck Squamous Cell Carcinoma
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 40
- Run by
- Xuekui Liu
See details and how to joinNCT07814287 - No phaseTaking peopleScreening of Biomarkers and Related Mechanisms for RIX
- Where
- Hangzhou, Nanjing
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07170358 - 1. fázisTaking peopleAkkermansia Muciniphila (AKK) for Radiation-Induced Skin Injury
- Where
- Chengdu
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- West China Hospital
See details and how to joinNCT07635277 - 2. fázisTaking peopleA Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC Participants
- Where
- Chengdu, Shanghai
- Életkor
- 18 év to 75 év
- People
- 120
- Run by
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
See details and how to joinNCT07668154 - 2. fázisTaking peopleTo Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for Patients With Recurrent Head and Neck Malignancies
- Where
- Xiamen
- Életkor
- 18 év to 75 év
- People
- 35
- Run by
- Neuboron Bio-SciTech Co., Ltd.
See details and how to joinNCT07795034 - 3. fázisTaking peopleA Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 180
- Run by
- Lepu Biopharma Co., Ltd.
See details and how to joinNCT05751512 - Korai 1. fázisTaking peopleThe Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
- Where
- Wuxi
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- FindCure Biosciences (ZhongShan) Co., Ltd.
See details and how to joinNCT07459283 - No phaseTaking peopleA Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions
- Where
- Nanjing
- Életkor
- 18 év to 100 év
- People
- 3000
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07532538 - 1. fázisTaking peopleIntratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors
- Where
- Chengdu
- Életkor
- 18 év to 65 év
- People
- 9
- Run by
- West China Hospital
See details and how to joinNCT07625423 - No phaseTaking peopleOnline Sharing for Head & Neck Cancer Support
- Where
- Chengdu
- Életkor
- 18 év to 75 év
- People
- 120
- Run by
- West China Hospital
See details and how to joinNCT07766226 - 2. fázisTaking peopleLow-Dose Radiotherapy and Anti-PD-1 Immunotherapy as Neoadjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Guangdong
- Életkor
- 18 év to 75 év
- People
- 22
- Run by
- Rui You
See details and how to joinNCT07371234 - No phaseTaking peopleApplication of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 750
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06755567 - No phaseTaking peopleTrop2-targeting NIR-II Molecular Probe for Precision Diagnosis of Oral Cancer
- Where
- Kunming
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- Yunnan Cancer Hospital
See details and how to joinNCT07794813 - 1. fázisTaking peopleA Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor
- Where
- Changsha, Chongqing, Guangzhou, Shanghai, Taiyuan, Wuhan
- Életkor
- 18 év to 75 év
- People
- 570
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05194982 - 2. fázisNot yet taking people in KínaA Study of BL-M08D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07788950 - 2. fázisNot yet taking people in KínaResponse-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck Cancer
- Where
- Changsha, Shanghai
- Életkor
- 18 év to 75 év
- People
- 85
- Run by
- Fudan University
See details and how to joinNCT07780877 - 2. fázisTaking peopleSintilimab Plus Hypofractionated Radiotherapy Followed by Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 27
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07781072 - 1. fázisTaking peopleA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 299 worldwide
- Run by
- Huahui Health
See details and how to joinNCT07623369 - 2. fázisNot yet taking people in KínaA Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination With Toripalimab for Resectable Locally Advanced Oral Squamous Cell Carcinoma
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Shanghai East Hospital
See details and how to joinNCT07778368